BME:MVCReal Estate
Metrovacesa (BME:MVC) Valuation Check After Strong Full Year Profit Rebound
Metrovacesa earnings spark fresh interest in the stock
Metrovacesa (BME:MVC) has attracted fresh attention after reporting full year 2025 net income of €56.86 million, compared with €15.89 million a year earlier, alongside higher basic and diluted earnings per share from continuing operations.
See our latest analysis for Metrovacesa.
The earnings release comes after a strong run in the shares, with a 30-day share price return of 30.26% and a 38.89% year to date share price return. The 5-year...